A comparative review on the pathogenicity and virulence factors of meticillin-resistant and meticillin-susceptible Staphylococcus aureus

Reviews and Research in Medical Microbiology

Volumn 21, Issue 2, 2010, Pages 31-37

  Kocsis, Erika ^a   Kristóf, Katalin ^a   Hermann, Péter ^b   Rozgonyi, Ferenc ^c  

^a Division of Microbiology Diagnostic Laboratory   (United States)

^b Faculty of Dentistry   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Community acquired meticillin resistant Staphylococcus aureus; Gene combinations; Hospital associated meticillin resistant Staphylococcus aureus; Meticillin resistant Staphylococcus aureus; Meticillin susceptible Staphylococcus aureus

Indexed keywords

ADHESIN; BACTERIAL TOXIN; CELL SURFACE PROTEIN; COAGULASE; CYTOTOXIN; DEOXYRIBONUCLEASE; ENTEROTOXIN; GELATINASE; HYALURONIDASE; PHOSPHATASE; SUPERANTIGENIC EXOTOXIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTERIAL CELL; BIOFILM; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COMPARATIVE STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HOSPITAL COST; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; IN VIVO STUDY; KINETICS; LIPID COMPOSITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIN SYNTHESIS;

EID: 77951073142     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e3283393cd4     Document Type: Review

References (69)

1. Rozgonyi F, Kocsis E, Kristó f K, Nagy K. Is MRSA more virulent than MSSA? Clin Microbiol Infect 2007; 13:843-845.
2. Jevons PM. 'Celbenin' -resistant staphylococci. Brit Med J 1961; 1:124-125.
3. Tiemersma EW, Bronzwaer SL, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2000. Emerg Infect Dis 2004; 10:1627-1634. (Pubitemid 39201515)
4. Borg MA, de Kraker M, Scicluna E, van de Sande-Bruinsma N, Tiemersma E, Monen J, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007; 60:1310-1315.
5. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000; 44:1549-1555.
6. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48:2637-2651.
7. Oliveira DC, Milheiriço C, de Lencastre H. Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI. Antimicrob Agents Chemother 2006; 50: 3457-3459.
8. Peacock JE Jr, Moorman DR, Wenzel RP, Mandell GL. Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulenceofanepidemic strain. J InfectDis1981;144:575-582.
9. Rozgonyi F, Laczkó J, Váczi L. Phenotypic expression of resistance to penicillinase-stable beta-lactams in Staphylococcus aureus: growth rate, cross wall morphogenesis and cell division cycle. FEMS Microbiol Lett 1982; 14:237-240.
10. Mizobuchi S, Minami J, Jin F, Matsushita O, Okabe A. Comparison of the virulence of methicillin-resistant and methicillinsensitive Staphylococcus aureus. Microbiol Immunol 1994; 38:599-605.
11. Karauzum H, Ferry T, de Bentzmann S, Lina G, Bes M, Vandenesch F, et al. Comparison of adhesion and virulence of two predominant hospital-acquired methicillin-resistant Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus isolates. Infect Immun 2008; 76:5133-5138.
12. Rozgonyi F. Pathogenic role, virulence, phenotype and mechanism of methicillin resistance in Staphylococcus aureus strains. Academic Doctoral Theses, Hungarian Academy of Sciences; 1987.
13. Rozgonyi F, Rédai I. The effect of methicillin in combination with trypsin and lysozyme on the growth of methicillin sensitive and resistant Staphylococcus aureus strains. Acta Microbiol Acad Sci Hung 1972; 19:133-143.
14. Rozgonyi F, Seltmann G. Pathogenicity and virulence of methicillin- resistant Staphylococcus aureus: slime layer production. Acta Microbiol Hung 1985; 32:155-165.
15. Smith K, Perez A, Ramage G, Lappin D, Gemmell CG, Lang S. Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J Med Microbiol 2008; 57:1018-1023.
16. O'Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 2007; 45:1379-1388.
17. Rozgonyi F, Kiss J, Lévai G, Biacs P, Váczi L. Phenotypic expression of methicillin resistance in Staphylococcus aureus. In: Mitsuhashi S, Rosival L, Krcméry V,editors. PLASMID: medical and theoretical aspects Berlin-Heidelberg-New York: AVICENUM, Prague, and Springer-Verlag; 1977. pp. 353-360.
18. Rozgonyi F, Mamo W, Fröman G, Ljungh A, Hjerten S, Wadström T. Cell-surface hydrophobicity and serum-protein bindings of methicillin-resistant and -susceptible staphylococcal strains. Zbl Bakt 1991; (Suppl 21):123-125.
19. Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger- Bächi B. Introduction of the mec element (methicillin resistance) into Staphylococcus aureus alters in-vitro functional activities of fibrinogen and fibronectin adhesins. Antimicrob Agents Chemother 1998; 42:564-570.
20. Salgado MM, Pignatari ACC, Bellinati-Pires R. Phagocytosis and killing of epidemic methicillin-resistant Staphylococcus aureus by human neutrophils and monocytes. Braz J Infect Dis 2004; 8:80-89.
21. Cree RG, Aleljung P, Paulsson M, Witte W, Noble WC, Ljungh A, et al. Cell surface hydrophobicity and adherence to extracellular matrix proteins in two collections of methicillin-resistant Staphylococcus aureus. Epidemiol Infect 1994; 112:307-314.
22. Duckworth GJ, Jordens JZ. Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. J Med Microbiol 1990; 32:195-200.
23. Asai S, Noda M, Yamamura M, Hozumi Y, Takase I, Nitta H, et al. Comparative study of the cellular fatty acids of methicillin- resistant and -susceptible Staphylococcus aureus. APMIS 1993; 101:753-761.
24. Ward TT. Comparison of in vitro adherence of methicillinsensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells. J Infect Dis 1992; 166:400-404.
25. Jordens JZ, Duckworth GJ, Williams RJ. Production of 'virulence factors' by 'epidemic' methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol 1989; 30:245-252.
26. Cutler RR. Relationship between antibiotic resistance, the production of 'virulence factors', and virulence for experimental animals in Staphylococcus aureus. J Med Microbiol 1979; 12:55-62.
27. Dornbusch K, Hallander HO, Lö fquist F. Extrachromosomal control of methicillin resistance and toxin production in Staphylococcus aureus. J Bacteriol 1969; 98:351-358.
28. Coia JE, Browning L, Haines L, Birbeck TH, Platt DJ. Comparison of enterotoxins and haemolysins produced by methicillinresistant (MRSA) and sensitive (MSSA) Staphylococcus aureus. J Med Microbiol 1992; 36:164-171.
29. Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 1997; 13:699-708. (Pubitemid 27375076)
30. Hu D-L, Omoe K, Inoue F, Kasai T, Yasujima M, Shinagawa K, et al. Comparative prevalence of superantigenic toxin genes in meticillin-resistant and meticillin-susceptible Staphylococcus aureus isolates. J Med Microbiol 2008; 57:1106-1112.
31. Peck KR, Baek JY, Song J-H, Ko KS. Comparison of genotypes and enterotoxin genes between Staphylococcus aureus isolates from blood and nasal colonizers in a Korean Hospital. J Korean Med Sci 2009; 24:585-591.
32. Kocsis E, Lagler H, Pesti N, Stich K, Kristó f K, Nagy K, et al. Comparison of Austrian, Hungarian and Macedonian methicillin- resistant and methicillin-sensitive Staphylococcus aureus strains in relation to prevalence of cytotoxin genes. Microb Pathog 2009; 46:328-336.
33. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau- Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42:2080-2084.
34. Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006; 12:29-34.
35. Rozgonyi F, Kovács L, Váczi L. Genotypic stability of methicillin resistance in Staphylococcus aureus after persistence in mice. In: Mitsuhashi S, Krcméry V, Antal M, Rosival L,editors. Transferable antibiotic resistance plasmid and gene manipulation, Springer Verlag Berlin, Heidelberg, New York, Tokyo: Avicenum Czechoslovak Medical Press Prague; 1984. pp. 269-273.
36. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD, Hancock GA, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114:107-112.
37. Pujol M, Pena C, Pallares R, Ariza J, Ayats J, Dominguez MA, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100:509-516.
38. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776-782.
39. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992; 13:587-593.
40. Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med 1993; 19:285-289.
41. Selvey LA, Whitby M, Johnson B. Nosocomial methicillinresistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?. Infect Control Hosp Epidemiol 2000; 21:645-648.
42. Topeli A, Ünal S, Akalin HE. Risk factors influencing clinical outcome in Staphylococcus aureus bacteremia in Turkish University Hospital. Internat J Antimicrob Agents 2004; 14: 57-63.
43. Oliveira DC, Tomasz A, de Lancester H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002; 2:180-189.
44. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillinresistant Staphylococcus aureus more virulent than methicillin - susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003; 37:1453-1460.
45. Shurland S, Zhan M, BradhamDD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillinresistant and methicillin- susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:273-279.
46. Whitby M, Mc Laws ML, Berry G. Risk of death from methicillin- resistant Staphylococcus aureus bacteraemia: a metaanalysis. Med J Aust 2001; 175:264-267.
47. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Rüden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection 2005; 33:50-55.
48. Lodise TP, Mckinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diag Microbiol Infect Dis 2005; 52:113-122.
49. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karschmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
50. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25:181-185.
51. Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries. Clin Infect Dis 2009; 49:997-1005.
52. Vriens MR, Fluit AC, Troelstra A, Verhoef J, van der Werken C. Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?. Infect Control Hosp Epidemiol 2002; 23:491-494.
53. Dufour P, Gillet Y, Bes M, Lina G, Vandanesch F, Floret D, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819-824.
54. Witte W, Braulke C, Cuny C, Stommenger B, Werner G, Heuck D, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005; 24:1-5.
55. O' Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA, et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 2004; 42:3185-3190.
56. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189:1565-1573.
57. Asensio A, Cantón R, Vaqué J, Rosselló J, Calbo F, Garća- Caballero J, et al. Nosocomial and community-acquired meticillin- resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect 2006; 63: 465-471.
58. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-984.
59. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100-107.
60. Bentzmann S, Tristan A, Etienne J, Brousse N, Vandanesh F, Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 2004; 190:1506-1515.
61. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin- resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008; 46:799-806.
62. Vardakas KZ, Matthaiou DK, Falagas ME. Comparison of community- acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin. Int J Tuberc Lung Dis 2009; 13:1476-1485.
63. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
64. Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007; 54:427-434.
65. Säd-Salim B, Mathema B, Braughton K, Davis S, Sinsimer D, Eisner W, et al. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 2005; 43:3373-3379.
66. Monecke S, Slickers P, Hotzel H, Richter-Huhn G, Pohle M, Weber S, et al. Microarray-based characterisation of a Panton- Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006; 12:718-728.
67. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillinresistant isolates. Clin Infect Dis 2003; 37:1050-1058.
68. Jung S-I, Shin DH, Park KH, Shin JH. Antimicrobial susceptibility and clonal relatedness between community- and hospital- acquired methicillin-resistant Staphylococcus aureus from blood cultures. J Microbiol 2006; 44:336-343.
69. Davis SL, Rybak MJ, Amjad M, Kaatz GW, McKinnon PS. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006; 27:1025-1031.